I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 27% ± 6% | |
| basal cell | 3 studies | 28% ± 5% | |
| secretory cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 27% ± 6% | |
| basal cell | 3 studies | 28% ± 5% | |
| secretory cell | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of RNF39 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 91% | 757.36 | 222 / 245 | 93% | 9.55 | 465 / 502 |
| stomach | 67% | 504.19 | 239 / 359 | 88% | 9.30 | 252 / 286 |
| breast | 61% | 991.43 | 278 / 459 | 85% | 9.70 | 955 / 1118 |
| lung | 47% | 147.50 | 271 / 578 | 89% | 11.14 | 1030 / 1155 |
| esophagus | 39% | 761.07 | 569 / 1445 | 96% | 18.37 | 175 / 183 |
| bladder | 48% | 436.81 | 10 / 21 | 86% | 9.49 | 434 / 504 |
| ovary | 27% | 71.52 | 49 / 180 | 90% | 12.31 | 389 / 430 |
| skin | 75% | 4203.91 | 1362 / 1809 | 42% | 2.98 | 198 / 472 |
| pancreas | 13% | 34.62 | 44 / 328 | 92% | 14.54 | 163 / 178 |
| brain | 10% | 26.53 | 267 / 2642 | 90% | 5.77 | 638 / 705 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.06 | 1 / 1 |
| intestine | 2% | 6.55 | 22 / 966 | 94% | 10.43 | 496 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 14.23 | 42 / 45 |
| uterus | 7% | 87.59 | 12 / 170 | 86% | 15.90 | 395 / 459 |
| thymus | 1% | 3.16 | 9 / 653 | 63% | 3.42 | 382 / 605 |
| adrenal gland | 10% | 24.62 | 27 / 258 | 43% | 5.06 | 99 / 230 |
| kidney | 6% | 15.01 | 5 / 89 | 18% | 0.77 | 159 / 901 |
| eye | 0% | 0 | 0 / 0 | 16% | 0.50 | 13 / 80 |
| liver | 0% | 0 | 0 / 226 | 15% | 0.89 | 62 / 406 |
| adipose | 10% | 38.04 | 118 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.09 | 1 / 29 |
| blood vessel | 0% | 2.60 | 5 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.45 | 2 / 803 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.71 | 2 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.44 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | RNF39 |
| Protein name | HCGV protein (HZFW1 protein) (Ring finger protein 39, isoform CRA_a) RING finger protein 39 (Protein HZFw) Ring finger protein 39 RING finger protein 39 |
| Synonyms | HCGV hCG_1640404 HZFW HZFW1 |
| Description | FUNCTION: May play a role in prolonged long term-potentiation (LTP) maintenance. . |
| Accessions | ENST00000244360.8 ENST00000457092.6 [Q9H2S5-2] ENST00000450015.2 [Q9H2S5-1] ENST00000451425.6 [Q9H2S5-2] ENST00000442378.2 [Q9H2S5-2] ENST00000376751.8 A0A140T901 ENST00000441449.6 [Q9H2S5-2] Q2L6J4 ENST00000432647.2 [Q9H2S5-1] A0A140T8Y9 ENST00000417541.6 ENST00000456156.6 [Q9H2S5-1] Q9H2S5 ENST00000442063.2 [Q9H2S5-2] ENST00000376750.6 Q96QB5 ENST00000449145.2 ENST00000383611.2 ENST00000420562.2 ENST00000425956.6 [Q9H2S5-1] |
